title: Long term survivors of childhood cancer: cure and care. The Erice statement.
abstract: The number of subjects that have successfully completed treatment for a cancer diagnosed during childhood and are entering adulthood is increasing over time. Members of the International Berlin-Frankfurt-Munster (I-BFM) Early and Late Toxicity Educational Committee (ELTEC) invited 45 paediatric cancer experts (representing oncologists, psychologists, nurses, epidemiologists, parents, and survivors) from 13 European countries (with five additional experts from North America) to Erice, Sicily (from October 27 to 29, 2006) to discuss the circumstances in which the word 'cure' should be used when speaking about children with cancer, and when and why continuing follow-up and care may be required. The objective of the gathering was to generate from the personal and professional experience of the participants an overview statement of the group's philosophy of cure and care of survivors of childhood cancer. The ten points reflect what the group considers essential in the survivors' cure and care.
authors.affiliation: Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Haupt
authors.forename: John J
authors.initials: JJ
authors.lastname: Spinetta
authors.forename: Irina
authors.initials: I
authors.lastname: Ban
authors.forename: Ronald D
authors.initials: RD
authors.lastname: Barr
authors.forename: Joern D
authors.initials: JD
authors.lastname: Beck
authors.forename: Julianne
authors.initials: J
authors.lastname: Byrne
authors.forename: Gabriele
authors.initials: G
authors.lastname: Calaminus
authors.forename: Eva
authors.initials: E
authors.lastname: Coenen
authors.forename: Mark
authors.initials: M
authors.lastname: Chesler
authors.forename: Giulio J
authors.initials: GJ
authors.lastname: D'Angio
authors.forename: Christine
authors.initials: C
authors.lastname: Eiser
authors.forename: Andreas
authors.initials: A
authors.lastname: Feldges
authors.forename: Faith
authors.initials: F
authors.lastname: Gibson
authors.forename: Herwig
authors.initials: H
authors.lastname: Lackner
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Masera
authors.forename: Luisa
authors.initials: L
authors.lastname: Massimo
authors.forename: Edina
authors.initials: E
authors.lastname: Magyarosy
authors.forename: Jacques
authors.initials: J
authors.lastname: Otten
authors.forename: Gregory
authors.initials: G
authors.lastname: Reaman
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Valsecchi
authors.forename: Anjo J P
authors.initials: AJ
authors.lastname: Veerman
authors.forename: Anthony
authors.initials: A
authors.lastname: Penn
authors.forename: Anne
authors.initials: A
authors.lastname: Thorvildsen
authors.forename: Cor
authors.initials: C
authors.lastname: van den Bos
authors.forename: Momcilo
authors.initials: M
authors.lastname: Jankovic
mesh_terms: D018572:Disease-Free Survival; D006801:Humans; D009369:Neoplasms / Q000401:mortality* / Q000628:therapy; D011379:Prognosis; D017741:Survivors